# Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With <i>EGFR</i> T790M–Mutated Non–Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-of-osimertinib-plus-bevacizumab-vs-osimertinib-in-patients-with-i-egfr/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hiroaki Akamatsu,Yukihiro Toi,Hidetoshi Hayashi,Daichi Fujimoto,Motoko Tachihara,Naoki Furuya,Sakiko Otani,Junichi Shimizu,Nobuyuki Katakami,Koichi Azuma,Naoko Miura,Kazumi Nishino,Satoshi Hara,Shunsuke Teraoka,Satoshi Morita,Kazuhiko Nakagawa,Nobuyuki Yamamoto |
| Citations | 187 |
| DOI | 10.1001/jamaoncol.2020.6758 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://jamanetwork.com/journals/jamaoncology/articlepdf/2774521/jamaoncology_akamatsu_2021_oi_200101_1615397480.54429.pdf |
| OpenAlex ID | https://openalex.org/W3119146950 |
| PMID | 33410885 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Hiroaki Akamatsu](https://scholariq.org/researchers/hiroaki-akamatsu/)
- [Daichi Fujimoto](https://scholariq.org/researchers/daichi-fujimoto/)
- [Nobuyuki Yamamoto](https://scholariq.org/researchers/nobuyuki-yamamoto/)

## Paper journal

- [JAMA Oncology](https://scholariq.org/journals/jama-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.